Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11148527.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a randomized, double-blind controlled trial, 42 children with irritable bowel syndrome (IBS) were given pH-dependent, enteric-coated peppermint oil capsules or placebo. After 2 weeks, 75% of those receiving peppermint oil had reduced severity of pain associated with IBS. Peppermint oil may be used as a therapeutic agent during the symptomatic phase of IBS.
Medical subject headings
- Colonic Diseases, Functional
- Parasympatholytics
- Plant Oils
- Tablets, Enteric-Coated